The FDA is proposing to remove phenylephrine from common over-the-counter decongestants due to lack of effectiveness against nasal congestion. Products like Sudafed PE, Vicks Sinex, and Benadryl Allergy Plus Congestion contain phenylephrine but have been found ineffective. The proposal is open for comments until May 7 and is specific to the oral form of phenylephrine, not the nasal spray. The FDA’s decision is based on a lack of evidence supporting its efficacy, as well as concerns about potential side effects at higher doses. Alternative treatments are available for nasal congestion, and the FDA urges consumers to explore other options.
Source link
FDA proposes ban on a ‘useless’ decongestant, phenylephrine
